Katsumata Yoshinori, Kohsaka Shun, Ikemura Nobuhiro, Ueda Ikuko, Hashimoto Kenji, Yamashita Terumasa, Miyama Hiroshi, Fujisawa Taishi, Kimura Takehiro, Tanimoto Kojiro, Momiyama Yukihiko, Suzuki Masahiro, Fukuda Keiichi, Takatsuki Seiji
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
JACC Clin Electrophysiol. 2021 May;7(5):565-574. doi: 10.1016/j.jacep.2020.10.016. Epub 2020 Dec 24.
This study sought to investigate whether symptom under-recognition is associated with the application of catheter ablation.
Atrial fibrillation (AF) symptom burden is frequently under-recognized and may affect the choice of treatment strategies.
A total of 3,276 patients with AF consecutively registered in a Japanese multicenter database from 2012 to 2017 were analyzed. All patients underwent AF symptom burden assessment via the symptom and daily activities domain within the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire. For the present analysis, 1,173 symptomatic patients (AFEQT score ≤80) with a clinical indication for catheter ablation were included. Under-recognition of symptom burden was defined as no subjective complaints checked by physicians despite self-reported AFEQT scores ≤80. Logistic regression analysis identified the predictors associated with receiving catheter ablation.
Of the 1,173 patients (age: 68 ± 12 years, men: 61%) analyzed, 459 underwent catheter ablation (ablation group); they had lower overall AFEQT scores (p < 0.01 for all domains) compared with the nonablation group. At the 1-year follow-up, greater improvement in the AFEQT scores was noted in the ablation group, even after adjusting for clinically relevant factors (+20.0 ± 1.2, +14.2 ± 0.9, respectively; p < 0.001). Notably, 306 (28%) patients met the criteria for symptom under-recognition, which was associated with the nonuse of catheter ablation during follow-up (odds ratio: 0.41; 95% confidence interval: 0.28 to 0.60; p < 0.001).
Under-recognition of AF symptom burden was frequently noted and was associated with less use of catheter ablation. Standardized recognition of symptoms using the application of validated questionnaires may facilitate outcome improvement.
本研究旨在调查症状未被充分认识是否与导管消融术的应用有关。
房颤(AF)的症状负担常常未被充分认识,这可能会影响治疗策略的选择。
对2012年至2017年连续纳入日本多中心数据库的3276例房颤患者进行分析。所有患者均通过房颤对生活质量影响(AFEQT)问卷中的症状和日常活动领域进行房颤症状负担评估。本次分析纳入了1173例有导管消融临床指征的有症状患者(AFEQT评分≤80)。症状负担未被充分认识定义为尽管患者自我报告AFEQT评分≤80,但医生未发现主观症状。逻辑回归分析确定了与接受导管消融相关的预测因素。
在分析的1173例患者(年龄:68±12岁,男性:61%)中,459例接受了导管消融(消融组);与非消融组相比,他们的总体AFEQT评分更低(所有领域p<0.01)。在1年随访时,即使在调整了临床相关因素后,消融组的AFEQT评分改善更大(分别为+20.0±1.2、+14.2±0.9;p<0.001)。值得注意的是,306例(28%)患者符合症状未被充分认识的标准,这与随访期间未使用导管消融有关(比值比:0.41;95%置信区间:0.28至0.60;p<0.001)。
房颤症状负担未被充分认识的情况较为常见,且与导管消融术的使用较少有关。使用经过验证的问卷对症状进行标准化识别可能有助于改善治疗结果。